Jie Cao

PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells

F. Wei, Wenwen Yu, Xiubao Ren, 2023, NPJ precision oncology.

Vemurafenib for BRAF V600‐mutant Erdheim–Chester disease presenting with bilateral orbital involvement

B. Meng, Xiaomeng Wang, S. Cao, 2023, Clinical case reports.